BioSpace News Archive

Business

Five Women Blazing Trails in Life Sciences Venture Capital

Bio Buzz selected five women venture capitalists who are considered “trailblazing investors shaping the future of life science investing” in the BioCapital Hotbed Community, which includes Delaware, Maryland, Virginia and Washington, D.C.

November 27, 2019
·
2 min read
·
Alex Keown
How to Show Your Co-Workers You’re Thankful for Them

Regardless of your situation, the holidays are a busy time for just about anyone. But don’t forget about the people you’ve been sitting next to all day, every day for the better part of a year — your co-workers.

November 27, 2019
·
2 min read
·
Laura Brothers
BioSpace Global Roundup, Nov. 28

Companies from across the globe provide updates on their businesses and pipelines.

November 27, 2019
·
4 min read
·
Alex Keown
Drug Development

Clinical Catch-Up: November 25-29

Even with a shortened week due to the U.S. Thanksgiving holiday, there was plenty of clinical trial news and updates. Here’s a look.

November 27, 2019
·
6 min read
·
Mark Terry
COPD Market Expected to Grow as Number of Cases Continues Rising

While there is no cure for the disease, there are a number of drugs that have been approved to treat the illness. And with the growing number of cases, the drug market for COPD is expected to dramatically increase as well.

November 27, 2019
·
3 min read
·
Alex Keown
Business

BioSpace Movers & Shakers, Nov. 29

Pharma and life science companies strengthen their leadership teams and boards of directors with this week’s appointments.

November 27, 2019
·
4 min read
·
Alex Keown
Herpes Vaccine: Despite Setbacks, There is Still Hope

There are currently three antivirals approved by the U.S. Food and Drug Administration (FDA) for genital herpes. They are acyclovir (Sitavig and Zovirax), valacyclovir (Valtrex), and famciclovir (Famvir). There are no approved vaccines.

November 27, 2019
·
4 min read
·
Mark Terry
MaxiVAX awarded €2,785,000 European Commission grant and announces successful closing of its Series B 2 round for an amount of CHF 5 million

MaxiVAX wins grant among 94 projects funded out of 2,015 applications

November 27, 2019
·
3 min read
Biotech Bay

Ultragenyx to Present at Piper Jaffray 31st Annual Healthcare Conference

Ultragenyx Pharmaceutical Inc. today announced that Shalini Sharp, the company’s Chief Financial Officer, will present at the Piper Jaffray 31ST Annual Healthcare Conference on Wednesday, December 4, 2019 at 2:00 PM ET in New York, NY.

November 27, 2019
·
1 min read
Drug Development

Eisai to Present Latest Data on Perampanel at the 73rd American Epilepsy Society Annual Meeting

Eisai Co., Ltd. has announced that the latest data on its antiepileptic drug (AED) perampanel (product name: Fycompa) will be presented at the 73rd American Epilepsy Society Annual Meeting (AES 2019) to be held from December 6 to December 10, 2019 in Baltimore, Maryland in the United States.

November 27, 2019
·
4 min read